• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Olicon lands Bell Atlantic as OEM

Article

PACS developer Olicon Imaging Systems of San Clemente, CA, hassigned a joint marketing agreement with Bell Atlantic NetworkServices, Olicon announced last month. The agreement will be implementedby Philadelphia-based Bell Atlantic's Large Business

PACS developer Olicon Imaging Systems of San Clemente, CA, hassigned a joint marketing agreement with Bell Atlantic NetworkServices, Olicon announced last month. The agreement will be implementedby Philadelphia-based Bell Atlantic's Large Business Servicesdivision.

The deal will give Olicon access to Bell Atlantic's large salesforce and expands Olicon's growing list of OEM partners. The companyrecently signed a similar agreement with Du Pont's diagnosticimaging group (SCAN 7/6/95).

The agreement will enable Bell Atlantic to offer Olicon's PACSproducts to new and existing health-care customers. Olicon hasbegun training Bell Atlantic personnel to perform field demonstrationsof Olicon PACS products.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.